FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167160417> ?p ?o ?g. }

• W2167160417 endingPage "5" @default.
• W2167160417 startingPage "482" @default.
• W2167160417 abstract "Members of the transforming growth factor beta (TGF-beta) family are potent inhibitors of the growth of many epithelial cell types. Transmembrane signaling by TGF-beta occurs via a complex of the serine/threonine kinases TGF-beta type 1 receptor and TGF-beta type 2 receptor (TGFBR2), and inactivating mutations in the latter have recently been detected in some primary tumors and in several types of tumor-derived cell lines. The most common mutations that have been identified in TGFBR2 are frameshifts in a repetitive polyadenine region in replication error-positive colorectal carcinomas that result in a truncated protein and absence of receptor expression at the cell surface. A number of point mutations in the highly conserved serine/threonine kinase domain of TGFBR2 have also been reported, some of which have been correlated with either loss of trans-phosphorylation of TGF-beta type 1 receptor or constitutive activation of trans-phosphorylation. No TGFBR2 mutations have been reported in human breast tumors, but anomalous expression of TGF-beta in breast carcinomas suggests that TGF-beta signaling may be defective. We have therefore systematically examined unmatched sets of 17 primary and 17 recurrent breast tumor samples for mutations in TGFBR2, restricted to those regions of the gene in which mutations have previously been reported. None of the previously reported mutations was detected, but four novel mutations (V387M, N435S, V447A, and L452M) were found in the kinase domain in recurrent tumors. No mutations were detected in primary tumors. TGF-beta signaling was significantly inhibited by each of the N435S, V447A, and L452M mutations." @default.
• W2167160417 created "2016-06-24" @default.
• W2167160417 creator A5007429139 @default.
• W2167160417 creator A5027846283 @default.
• W2167160417 creator A5029833703 @default.
• W2167160417 creator A5039947845 @default.
• W2167160417 creator A5042726249 @default.
• W2167160417 creator A5074583595 @default.
• W2167160417 creator A5076824079 @default.
• W2167160417 date "2001-01-15" @default.
• W2167160417 modified "2023-09-23" @default.
• W2167160417 title "Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer." @default.
• W2167160417 cites W1513040830 @default.
• W2167160417 cites W1665402587 @default.
• W2167160417 cites W1834610050 @default.
• W2167160417 cites W2005462392 @default.
• W2167160417 cites W2010206624 @default.
• W2167160417 cites W2019050177 @default.
• W2167160417 cites W2050704287 @default.
• W2167160417 cites W2062178963 @default.
• W2167160417 cites W2063321517 @default.
• W2167160417 cites W2070470162 @default.
• W2167160417 cites W2110815052 @default.
• W2167160417 cites W2124836069 @default.
• W2167160417 cites W2131815302 @default.
• W2167160417 cites W2135197529 @default.
• W2167160417 cites W2137393673 @default.
• W2167160417 cites W2163432183 @default.
• W2167160417 cites W2166460162 @default.
• W2167160417 cites W2330151932 @default.
• W2167160417 cites W2334063917 @default.
• W2167160417 cites W2612685756 @default.
• W2167160417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11212236" @default.
• W2167160417 hasPublicationYear "2001" @default.
• W2167160417 type Work @default.
• W2167160417 sameAs 2167160417 @default.
• W2167160417 citedByCount "31" @default.
• W2167160417 countsByYear W21671604172012 @default.
• W2167160417 countsByYear W21671604172015 @default.
• W2167160417 countsByYear W21671604172017 @default.
• W2167160417 countsByYear W21671604172018 @default.
• W2167160417 crossrefType "journal-article" @default.
• W2167160417 hasAuthorship W2167160417A5007429139 @default.
• W2167160417 hasAuthorship W2167160417A5027846283 @default.
• W2167160417 hasAuthorship W2167160417A5029833703 @default.
• W2167160417 hasAuthorship W2167160417A5039947845 @default.
• W2167160417 hasAuthorship W2167160417A5042726249 @default.
• W2167160417 hasAuthorship W2167160417A5074583595 @default.
• W2167160417 hasAuthorship W2167160417A5076824079 @default.
• W2167160417 hasConcept C10205521 @default.
• W2167160417 hasConcept C104317684 @default.
• W2167160417 hasConcept C111001777 @default.
• W2167160417 hasConcept C118131993 @default.
• W2167160417 hasConcept C125555471 @default.
• W2167160417 hasConcept C134018914 @default.
• W2167160417 hasConcept C153911025 @default.
• W2167160417 hasConcept C170493617 @default.
• W2167160417 hasConcept C171020997 @default.
• W2167160417 hasConcept C175554068 @default.
• W2167160417 hasConcept C176944494 @default.
• W2167160417 hasConcept C2775960820 @default.
• W2167160417 hasConcept C2778229498 @default.
• W2167160417 hasConcept C28328180 @default.
• W2167160417 hasConcept C501734568 @default.
• W2167160417 hasConcept C502942594 @default.
• W2167160417 hasConcept C54355233 @default.
• W2167160417 hasConcept C6061869 @default.
• W2167160417 hasConcept C62478195 @default.
• W2167160417 hasConcept C86803240 @default.
• W2167160417 hasConceptScore W2167160417C10205521 @default.
• W2167160417 hasConceptScore W2167160417C104317684 @default.
• W2167160417 hasConceptScore W2167160417C111001777 @default.
• W2167160417 hasConceptScore W2167160417C118131993 @default.
• W2167160417 hasConceptScore W2167160417C125555471 @default.
• W2167160417 hasConceptScore W2167160417C134018914 @default.
• W2167160417 hasConceptScore W2167160417C153911025 @default.
• W2167160417 hasConceptScore W2167160417C170493617 @default.
• W2167160417 hasConceptScore W2167160417C171020997 @default.
• W2167160417 hasConceptScore W2167160417C175554068 @default.
• W2167160417 hasConceptScore W2167160417C176944494 @default.
• W2167160417 hasConceptScore W2167160417C2775960820 @default.
• W2167160417 hasConceptScore W2167160417C2778229498 @default.
• W2167160417 hasConceptScore W2167160417C28328180 @default.
• W2167160417 hasConceptScore W2167160417C501734568 @default.
• W2167160417 hasConceptScore W2167160417C502942594 @default.
• W2167160417 hasConceptScore W2167160417C54355233 @default.
• W2167160417 hasConceptScore W2167160417C6061869 @default.
• W2167160417 hasConceptScore W2167160417C62478195 @default.
• W2167160417 hasConceptScore W2167160417C86803240 @default.
• W2167160417 hasIssue "2" @default.
• W2167160417 hasLocation W21671604171 @default.
• W2167160417 hasOpenAccess W2167160417 @default.
• W2167160417 hasPrimaryLocation W21671604171 @default.
• W2167160417 hasRelatedWork W189393563 @default.
• W2167160417 hasRelatedWork W2027104842 @default.
• W2167160417 hasRelatedWork W2039022971 @default.
• W2167160417 hasRelatedWork W2069282082 @default.
• W2167160417 hasRelatedWork W2167160417 @default.

• next